Webinar | July 17, 2019

Mitigating Risk Through Product Characterization

Source: MilliporeSigma

In this webinar, multiple approaches to characterizing the physico-chemical and structural attributes of therapeutic mAbs is presented with a focus on how it influences the resulting biological activity.

  • Characterization of therapeutic antibodies
    • what, why, and when
    • Benefits of early use of PC approaches to understand your product
  • Complexities of monoclonal (mAbs) and their characterization
  • Approaches to characterization of mAb physico-chemical and structural attributes
  • Functional characterization of mAbs